AnyTime News 
Big Investments Announced, But Several High-Value Projects Still Await Full Implementation
Pooja Srivastava | Anytime News Network
Loading...
Reload document
Open in new tab
India’s ambitious drive to become a global manufacturing hub for high-precision medical devices has gained momentum through multiple flagship schemes. However, official data also indicates that while policy announcements are substantial, the pace of implementation remains a key challenge.
Large PLI Outlay, Limited Incentive Disbursement
The Government’s ₹3,420-crore Production Linked Incentive (PLI) Scheme has attracted investments and enabled domestic production of advanced devices such as MRI systems, CT scanners, cardiac valves and stents. Yet, by FY 2024-25, only ₹266.64 crore had been released as incentives, highlighting the gap between announced allocations and actual disbursement.
Medical Device Parks Still Under Development
Medical Device Parks in Uttar Pradesh, Madhya Pradesh and Tamil Nadu continue to be under implementation. While ₹209.80 crore in Central assistance has been released, utilisation stands at ₹177.98 crore, suggesting that infrastructure creation is still a work in progress.
Infrastructure Projects Yet to Deliver Full Benefits
Several common testing facilities, prototype centres, biomedical implant laboratories and advanced manufacturing infrastructure projects remain under implementation. Until these become fully operational, manufacturers may not experience the complete ecosystem support envisioned under the policy.
Import Dependence Remains a Long-Term Challenge
Although the Government has approved 24 projects under the scheme aimed at reducing import dependence, industry experts believe India still has significant ground to cover before achieving large-scale self-reliance in sophisticated medical technologies.
Execution Will Define Success
The Government has highlighted encouraging investments, growing FDI and expanding domestic manufacturing capacity. However, the real measure of success will depend on faster project completion, stronger industrial adoption and India’s ability to compete globally in advanced medical technology manufacturing. The next phase is no longer about policy announcements—it is about delivering measurable outcomes on the ground.
